ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
scaffold_1_760 # 1009053 # 1009172 # 1 # ID=1_760;partial=00;start_type=ATG;rbs_motif=AAA;rbs_spacer=14bp;gc_cont=0.517	scaffold_1_760 	1009053	1009172	+	Strict	1000	19.631	lsaB	100.0	3003111	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGCTTCCTGAAAAGGTAGACTGGAAGCTTGGTTTCGCCAATTGGTTTGAGGCCTGGGATGATAGCTTTGCGGTGGCAGCAAGCCAATTTGTGACCCGGGCGTTGACCATGAATGGGTAG	MLPEKVDWKLGFANWFEAWDDSFAVAASQFVTRALTMNG	MSMIHVQNLTFSYPSSFDNIFEDVSFQIDTDWKLGFIGRNGRGKTTLFNLLLDKFEYRGKIISSVDFNYFPYPVEDKSKYTHEILEEICPQAEDWEFLREIAYLNVDAEAMYRPFETLSNGEQTKVLLVALFLNEGQFLLIDEPTNHLDTEARKTVSNYLRKKKGNILISHDRNFLDGSVDHILSINRADIEVQSGNYSSWKLNFDRQQGHEQATNERLQKDIGRLEQSTKRSAGWSNRVEASKNGTTNSGSKLDKGFVGHKAAKMMKRSKNLEARQQKSIEEKSKLLKNIEKTESLQFEPVEYKSKELIQLTDVSVIYDGQVVNKPISFNVEQGDRIVLDGKNGSGKSSILKLILGDPIQYTGTLNTGSNLITSYVQQDTSHLKGMLADFIEENEIDESLFKAILRKLDFDRVQFEKDISHYSGGQKKKLLIAKSLCEKAHLYIWDEPLNFIDIYSRMQIEELIQTFNPTMVFVEHDQTFQETISTKIIKI	7.93	gnl|BL_ORD_ID|1097|hsp_num:0	1161	True	loose hit with at least 95 percent identity pushed strict
scaffold_1_959 # 1242645 # 1242785 # 1 # ID=1_959;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.489	scaffold_1_959 	1242645	1242785	+	Strict	750	20.7866	smeD	100.0	3003055	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCATGGGATGTTGTTGATGAAAAAAAGGAGACGAAGGATTCACTTAGCGTGATGCTGGATCCTAGAATAGATGCGTCTTACAGGGCCCAAGCTCAGCTCATGTTGGACGGGACCCTGTCCGACAGCTCTTGGCTGTAA	MSWDVVDEKKETKDSLSVMLDPRIDASYRAQAQLMLDGTLSDSSWL	MLLSRIRPFALSLAIAATVAACGGQPQAPEQGPGDVTVVTLKSETVGLTRELPGRTNAFLVAEVRPQVNGIVAKRLFTEGGMVKAGEPLYQLDDASYRAQANNARAQLARAEATANAARLSAKRITELAKVDAVSQQDLENAVAAQKQAEADVGAAKASLDAANVTLGYARITAPISGRIGKSSVTQGALVSAGQANALATVQQLDPIYVDLTQSSAELLQLRRELAAGRLQDNQTLPVSILMEDGSTFEHKGTLEFSEVSVDPTTGSFGLRVKVDNPDGLLMPGMYVRAVIGGGVRSDAVLVPMQGIARDPKGDTTAMVVGKDNKVEVRPVKVSRTVGDKWLVEDGLKAGDKVIVEGLQKIGPGMPVKATEKGDAPAKPAAAAQPAAPAGDAK	11.68	gnl|BL_ORD_ID|263|hsp_num:0	284	True	loose hit with at least 95 percent identity pushed strict
scaffold_1_3919 # 5171533 # 5171655 # -1 # ID=1_3919;partial=00;start_type=ATG;rbs_motif=AAAA;rbs_spacer=13bp;gc_cont=0.382	scaffold_1_3919 	5171533	5171655	-	Strict	1250	21.557	mecC	100.0	3001209	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	ATGTACGAAATAGGTATTGTCCCTAATAATAACATATTGGATGGCCCTAGGTCGGTCTGTCACATGGGAACATTACATAATACTTCCCGACTTGACGTGGGAATTGATCTGATTTATATCTAG	MYEIGIVPNNNILDGPRSVCHMGTLHNTSRLDVGIDLIYI	MKKIYISVLVLLLIMIIITWLFKDDDIEKTISSIEKGNYNEVYKNSSEKSKLAYGEEEIVDRNKKIYKDLSVNNLKITNHEIKKTGKDKKQVDVKYNIYTKYGTIRRNTQLNFIYEDKHWKLDWRPDVIVPGLKNGQKINIETLKSERGKIKDRNGIELAKTGNTYEIGIVPNKTPKEKYDDIARDLQIDTKAITNKVNQKWVQPDSFVPIKKINKQDEYIDKLIKSYNLQINTIKSRVYPLNEATVHLLGYVGPINSDELKSKQFRNYSKNTVIGKKGLERLYDKQLQNTDGFKVSIANTYDNKPLDTLLEKKAENGKDLHLTIDARVQESIYKHMKNDDGSGTALQPKTGEILALVSTPSYDVYPFMNGLSNNDYRKLTNNKKEPLLNKFQITTSPGSTQKILTSIIALKENKLDKNTNFDIYGKGWQKDASWGNYNITRFKVVDGNIDLKQAIESSDNIFFARIALALGAKKFEQGMQDLGIGENIPSDYPFYKAQISNSNLKNEILLADSGYGQGEILVNPIQILSIYSALENNGNIQNPHVLRKTKSQIWKKDIIPKKDIDILTNGMERVVNKTHRDDIYKNYARIIGKSGTAELKMNQGETGRQIGWFVSYNKNNPNMLMAINVKDVQNKGMASYNATISGKVYDDLYDNGKTQFDIDQ	6.02	gnl|BL_ORD_ID|763|hsp_num:0	810	True	loose hit with at least 95 percent identity pushed strict
scaffold_4_279 # 289591 # 289809 # 1 # ID=4_279;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=3-4bp;gc_cont=0.406	scaffold_4_279 	289591	289809	+	Strict	475	21.1718	AAC(6')-Ib7	100.0	3002578	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGTATAATCATGATCAGTACTGTCTATATCTGTACTGTTTGTGTCAACTAAAGAAACTTTCCTCTGCTCTCTTTCTGTGTACTCATATTCTCGGCAGAAACTGGTCTCGGACGCTTTATATGATTCAGAAAAACAACTGCAACAACAGCAACAGCAACAACAACACAAGCCGCTACCAGCGAATAGGGATATCAATCGAAAAAAGGGGGCTTCTGTAG	MYNHDQYCLYLYCLCQLKKLSSALFLCTHILGRNWSRTLYMIQKNNCNNSNSNNNTSRYQRIGISIEKRGLL	MRSRNWSRTLTERSGGNGAVAVFMACYDCFFVQSMPRASKQQARYAVGRCLMLWSSNDVTQQGSRPKTKLGITKYSIVTNSNDSVTLRLMTEHDLAMLYEWLNRSHIVEWWGGEEARPTLADVQEQYLPSVLAQESVTPYIAMLNGEPIGYAQSYVALGSGDGWWEEETDPGVRGIDQLLANASQLGKGLGTKLVRALVELLFNDPEVTKIQTDPSPSNLRAIRCYEKAGFERQGTVTTPDGPAVYMVQTRQAFERTRSDA	27.59	gnl|BL_ORD_ID|1960|hsp_num:0	2117	True	loose hit with at least 95 percent identity pushed strict
scaffold_6_1695 # 2763127 # 2763405 # -1 # ID=6_1695;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.534	scaffold_6_1695 	2763127	2763405	-	Strict	375	21.9422	fusC	100.0	3003733	protein homolog model	n/a	n/a	fusidic acid	antibiotic target protection	Target protecting FusB-type protein conferring resistance to Fusidic acid	ATGGAGGGCAGTGACAATCTGATCTATTACAAGATGGGACGCGGAATGTTCAACAAGGGCTTTTGTAAGATATGCGCCACGCCAGTTGAGAATAAAGCGTCACAGCTCAGCGAGGAGCAGAGAGCAGCACTCCCTGAGGGTGCTCGTGTCTGGTATGACCGCGGACAAACGCAGCGGGCAACCAACTCGAGGATCCTCGATGGCTTCGATGTCAGTCGCCTCAAGAAGGAGCGCATCGATGGCTGGAACAACATCTTGCCAAAATACGAGAACCCTTGA	MEGSDNLIYYKMGRGMFNKGFCKICATPVENKASQLSEEQRAALPEGARVWYDRGQTQRATNSRILDGFDVSRLKKERIDGWNNILPKYENP	MNKIEVYKFVKVKQLVYQLIKLYRTNDMNSHKTQKDFLLNEINDIFKEKDIDISDFITSIDDVKLTKKKAEHLLNELKVYIQDFEIPSSSQLEKIFRKVKKLKRPDINLIDTKEISYLGWNDNSSNRKYIVYKNLDDKFEGIYGEISPNKVKGFCKICNQESDTSLFLNKTKHNKSSGTYTKKGDYICYDSFKCNQNLDDINNLYEFIVKIK	43.40	gnl|BL_ORD_ID|2116|hsp_num:0	2250	True	loose hit with at least 95 percent identity pushed strict
scaffold_7_433 # 483533 # 483664 # -1 # ID=7_433;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.576	scaffold_7_433 	483533	483664	-	Strict	700	20.7866	mgtA	100.0	3000462	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	mgt macrolide glycotransferase	ATGGCCTGGGAAGAACCGAGAAAGACTGGCATGGTCTACCGCCGACTGGGCAACTCTGGCCTTCACGTTTCGGCCATTGCCCTGGGTGGCTGGCTCACCTACGGTGGTCATGTTGAAGATGGTATGATATGA	MAWEEPRKTGMVYRRLGNSGLHVSAIALGGWLTYGGHVEDGMI	MKRKELHETSRLAYGRRMTTRPAHIAMFSIALHGHVNPSLEVIRELVARGHRVTYAIPPLLADKVAEAGAEPKLWNSTLPGPDADPEAWGSTLLDNVEPFLADAIQSLPQLAQAYEGDEPDLVLHDIASYTARVLGRRWEVPVISLSPCMVAWEGYEQEVGEPMWEEPRKTERGQAYYARFHAWLEENGITDHPDPFIGRPDRSLVLIPKALQPHADRVDETTYTFVGACQGDRTAEGDWARPEGAEKVVLVSLGSAFTKQPAFYRECVRAFGELPGWHTVLQVGRHVDPAELGDVPDNVEVRTWVPQLAILQQADLFVTHAGAGGSQEGLATATPMIAVPQAADQFGNADMLQGLGVARTLPTEEATAKALRTAALALVDDPEVAARLKEIQARMAQEGGTRRAADLIEAELAAARG	10.29	gnl|BL_ORD_ID|2357|hsp_num:0	515	True	loose hit with at least 95 percent identity pushed strict
scaffold_12_622 # 796250 # 796444 # -1 # ID=12_622;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.513	scaffold_12_622 	796250	796444	-	Strict	400	21.9422	vanRE	100.0	3002924	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	ATGGATTTCTCAGATCCCGAAGTCTTTGCCGCTTTGCCCCACGACAACCGTGGCAGTGTTGTGGTCGGTATTGTGTGCTTTGTCTTACTGGTCGCGTCGCTAGCGACTGGCGCGAGATTATATACCCGGCTTGTCATTGTGCAACAAATGGGCGCTGATGATTACATCGTTGCAATCGCTCTGGTTCGTACATAG	MDFSDPEVFAALPHDNRGSVVVGIVCFVLLVASLATGARLYTRLVIVQQMGADDYIVAIALVRT	MAKILILDDEKEIVSLLSTLLSNEGYEVYEAMSGKESLEIIENNKIDLAILDVMLPDISGFDVLQSIREKQFFPVLMLTARGQDMDKITGLSMGADDYIVKPFNPFEVLARVKTQLRRYQTYNSQSIDETNEYAKNGLNISVNSRKVFLYDEEIKLTPIEFDILWYLCRNEGRVISSEELFEKVWKEDYLENNNTVMAHIAKIREKMHEKPRQPNIIKTVWGVGYTIEK	27.95	gnl|BL_ORD_ID|650|hsp_num:0	691	True	loose hit with at least 95 percent identity pushed strict
scaffold_16_572 # 748452 # 748637 # -1 # ID=16_572;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.651	scaffold_16_572 	748452	748637	-	Strict	375	20.7866	fusB	100.0	3003552	protein homolog model	n/a	n/a	fusidic acid	antibiotic target protection	Target protecting FusB-type protein conferring resistance to Fusidic acid	ATGGCGCACAGCCAGGACAGCGAGTACCACGGCATCGCGTACCCGGTGGACGTGTTCGAGCTGCCGTCCCCCCAGATCGCCGCGTCGACGTCGTACGAGGTCACATCACAGGCCATATGGCAGACGGACTTGCCGATACTGCCAGCGCCCGCCGAGGAGGAAGAGGACGACGAACCCACGCCATGA	MAHSQDSEYHGIAYPVDVFELPSPQIAASTSYEVTSQAIWQTDLPILPAPAEEEEDDEPTP	MKTMIYPHQYNYIRSVILRLKNVYKTVNDKETVKVIQSETYNDINEIFGHIDDDIEESLKVLMNIRLSNKEIEAILNKFLEYVVPFELPSPQKLQKVFKKVKKIKIPQFEEYDLKVSSFVGWNELASNRKYIIYYDEKKQLKGLYGEISNQVVKGFCTICNKESNVSLFMKKSKTNSDGQYVKKGDYICRDSIHCNKQLTDINQFYNFIDKLD	28.64	gnl|BL_ORD_ID|19|hsp_num:0	24	True	loose hit with at least 95 percent identity pushed strict
scaffold_17_18 # 22753 # 22872 # -1 # ID=17_18;partial=00;start_type=ATG;rbs_motif=AACAA;rbs_spacer=13bp;gc_cont=0.433	scaffold_17_18 	22753	22872	-	Strict	525	19.631	myrA	100.0	3001300	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic	antibiotic target alteration	non-erm 23S ribosomal RNA methyltransferase (G748)	ATGGATTTGTATCATCAAAAATCCCGTCATCTCGTCATTCTTTCTTTGGTCGAAGCCATTGGAGATCAATTGATCTGGGATGATACCTGGGGAAGACTGGTGGTGATCAAGCCTTTATGA	MDLYHQKSRHLVILSLVEAIGDQLIWDDTWGRLVVIKPL	MHPDLLPHLRCPVCGQPLHQADAAPPRALRCPAGHSFDIARQGYVNLLTGRAPHVGDTAEMIAAREEFLAAGHYDPFSAALATAAARAVPRRVRPGDGVGEPVAYPDLVVDAGAGTGRHLAAVLDAVPTAVGLALDVSKPALRRAARAHPRAGAAVCDTWGRLPLADATVAVLVNVFAPRNGPEFRRVLRPDGALLVVTPTAEHLVELVDRLGLLRVDPAKDARVADSLTRHFEPAGQSTHRHRLQLTRKEVLTLVGMGPSAWHTDPARLTARVAALSEPVTVTAAVRLARYRPI	13.22	gnl|BL_ORD_ID|142|hsp_num:0	158	True	loose hit with at least 95 percent identity pushed strict
scaffold_18_247 # 301838 # 302062 # -1 # ID=18_247;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.538	scaffold_18_247 	301838	302062	-	Strict	500	21.9422	OXA-9	100.0	3001404	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAAGGCGTTCAAGAACAGACTCAAGCAGCCCGAAGCCTGGCTTCGTGAGAACCTGGAGCAAGTTGCCGTGCTGCACAAGACTGGCAGATTCGCCAACTACTGGGAACTGAAACCAGAGTATCAGAAGCGGAAGCCCAATGCCGACACTGCAGCGGCTGAAGTGGCTGATTTCGATGACGACGACGACGAGGACGATAATGTCGAAATGGAAGACGTCGTATAG	MKAFKNRLKQPEAWLRENLEQVAVLHKTGRFANYWELKPEYQKRKPNADTAAAEVADFDDDDDEDDNVEMEDVV	MKKILLLHMLVFVSATLPISSVASDEVETLKCTIIADAITGNTLYETGECARRVSPCSSFKLPLAIMGFDSGILQSPKSPTWELKPEYNPSPRDRTYKQVYPALWQSDSVVWFSQQLTSRLGVDRFTEYVKKFEYGNQDVSGDSGKHNGLTQSWLMSSLTISPKEQIQFLLRFVAHKLPVSEAAYDMAYATIPQYQAAEGWAVHGKSGSGWLRDNNGKINESRPQGWFVGWAEKNGRQVVFARLEIGKEKSDIPGGSKAREDILVELPVLMGNK	27.01	gnl|BL_ORD_ID|226|hsp_num:0	243	True	loose hit with at least 95 percent identity pushed strict
